Kyntra Bio (KYNB) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to 0.12.
- Kyntra Bio's Equity Ratio rose 8651.35% to 0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12, marking a year-over-year increase of 8651.35%. This contributed to the annual value of 1.05 for FY2024, which is 11815.48% down from last year.
- Per Kyntra Bio's latest filing, its Equity Ratio stood at 0.12 for Q3 2025, which was up 8651.35% from 1.25 recorded in Q2 2025.
- Kyntra Bio's 5-year Equity Ratio high stood at 0.5 for Q1 2021, and its period low was 1.31 during Q1 2025.
- Over the past 5 years, Kyntra Bio's median Equity Ratio value was 0.12 (recorded in 2025), while the average stood at 0.27.
- Per our database at Business Quant, Kyntra Bio's Equity Ratio plummeted by 127127.79% in 2023 and then skyrocketed by 8651.35% in 2025.
- Quarter analysis of 5 years shows Kyntra Bio's Equity Ratio stood at 0.3 in 2021, then crashed by 111.87% to 0.04 in 2022, then crashed by 1271.28% to 0.48 in 2023, then crashed by 118.15% to 1.05 in 2024, then surged by 88.18% to 0.12 in 2025.
- Its Equity Ratio stands at 0.12 for Q3 2025, versus 1.25 for Q2 2025 and 1.31 for Q1 2025.